RE:RE:RE:RE:RE:The success of LABS The application of a generic form of epidiolex for opiate addiction is very interesting and recall that the CEO did state that some of the data for the ANDA was from another party and I am now wondering if that is for the SEDDS technology used in a generic version of Epidiolex. Those data points now compiled together at least box in for me